Greenlight Biosciences Holdings Pbc (GRNA) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Greenlight Biosciences Holdings Pbc  (NASDAQ: GRNA)


Greenlight Biosciences Holdings Pbc's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Greenlight Biosciences Holdings Pbc's ROI in the first quarter of 2023?
Greenlight Biosciences Holdings Pbc recorded a cumulative net loss of $-157 million during 12 months ending in the first quarter of 2023, resulting in a negative return on investment (ROI) of -174.88%.

Within the Healthcare sector 954 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2022 from 4852 to 4909.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM -53.9 % -59.56 % -38.24 % 5.02 % 136.95 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 83 113 119 45 99
Return On Investment (TTM) -174.88 % -177.51 % -133.98 % -104.08 % -66.22 %
GRNA's Overall Ranking # 4909 # 4852 # 0 # 0 # 0
Seq. Investment Change TTM -4.42 % -22.62 % -17.79 % -24.19 % -16.15 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -157 -167 -163 -154 -129

GRNA Company Profile >> Back to GRNA Roi Comparisons >> See Annual GRNA Return On Investment



Return On Investment GRNA's Ranking
Within: No.
Industry # 151
Sector # 955
Overall # 4909

Return On Investment Statistics
High Average Low
-4.43 %
-79.47 %
-177.51 %
(Sep 30 2021)   (Dec 31 2022)







Financial Statements
Greenlight Biosciences Holdings Pbc's I. Quarter Investments $ 83 Millions GRNA's Balance sheet
Greenlight Biosciences Holdings Pbc's I. Quarter Income $ -28 Millions Quarterly GRNA's Income Statement
GRNA's Income by Division See GRNA's Income by Division


GRNA Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021


Total Investments in Millions 113 195 80 0 0
Y / Y Investment Growth -42.1 % 144.13 % - - -
Net Income in Millions -167 -15 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -147.79 % -7.71 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GRNA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GRNA's Competitors
Subscribers only: Roi for Greenlight Biosciences Holdings Pbc's Suppliers
Subscribers only: Return On Investment for GRNA's Customers

Other Ratios
GRNA's Roa GRNA's Inventory Turnover Ratio GRNA's Growth Rates GRNA's Dividend Statistics
GRNA's Profitability Ratios GRNA's Asset Turnover Ratio GRNA's Dividend Growth
GRNA's Roe GRNA's Valuation Ratios GRNA's Financial Strength Ratios GRNA's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.